Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Preferred Dividend Payments: 2019-2023

  • Cidara Therapeutics' Preferred Dividend Payments was N/A to $636,000 in Q1 2023 from the same period last year, while for Mar 2023 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $2.8 million for FY2020, which is N/A change from last year.
  • As of Q1 2023, Cidara Therapeutics' Preferred Dividend Payments stood at $636,000, which was down 79.36% from $3.1 million recorded in Q3 2022.
  • Cidara Therapeutics' 5-year Preferred Dividend Payments high stood at $3.1 million for Q3 2022, and its period low was $444,000 during Q3 2019.
  • Its 3-year average for Preferred Dividend Payments is $1.9 million, with a median of $1.9 million in 2021.